Skip to content

Clinical trials

Phase 2 Venous Thromboembolism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20061
20073
20081
20091
20121
20131
20153
20177
20211
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated5
Recruiting3
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Utah4
Bayer3
Daiichi Sankyo2
GlaxoSmithKline2
Boehringer Ingelheim1
Bryan Cotton1
Denver Health and Hospital Authority1
Fred Hutchinson Cancer Center1
M.D. Anderson Cancer Center1
New York Medical College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism27
Venous Thrombosis7
Pulmonary Embolism5
Neoplasms3
Atrial Fibrillation2
Glioblastoma2
Hematologic Diseases2
Thromboembolism2
Accidental Injuries1
Astrocytoma1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.